Key facts
- Notable investors include 1731 MGMT.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Ivory Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Ivory Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ivory Medical
Developer of plant-derived therapeutic formulations designed for wellness and symptom relief. The company's platform includes certified production of cannabinoid-based extracts such as distillates, isolates, and oil formulations, derived from locally cultivated cannabis, enabling healthcare providers and wellness brands to access consistent, high-quality ingredients and private-label products tailored for conditions like pain, anxiety, and sleep disorders.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Harare, Zimbabwe
- Founded
- 2018
- Website
- ivorymedicalzw.com/
- Ownership
- Privately Held (backing)
Ivory Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ivory Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ivory Medical in its N-PORT filings yet. We sweep new filings monthly.